3655 results for «294»

Filter By

3655 results

Tricuspid and other interventions for valvular disease

05 Oct 2024 – From AICT-AsiaPCR 2024

Immerse yourself in this captivating session featuring selected clinical case submissions from the AICT-AsiaPCR 2024 conference. Explore a wide range of interventional challenges, including device closure of ruptured sinus of Valsalva aneurysm, balloon valvotomy during pregnancy in a double orifice mitral valve, and unusual femoral complications....

Tricuspid and other interventions for valvular disease

Hybrid procedure: Stent and DCB for a long diffuse lesion - LIVE case

05 Oct 2024 – From AICT-AsiaPCR 2024

A 40-year-old male with no comorbidities presented an NSTEMI. The angiography showed a focus lesion on the mid-CX and a diffuse lesion on the mid and distal LAD. The LAD FFR are 0.49 with a diffuse pullback gradient.
After Stent in mid-CX guided by OCT, the operators...

Hybrid procedure: Stent and DCB for a long diffuse lesion - LIVE case

Complications in women: crash and burn or crash and save

05 Oct 2024 – From AICT-AsiaPCR 2024

Complications can arise even in the most experienced hands. This session explores a series of challenging cases involving women, from a detached mitral clip to a calcified vessel perforation. Witness the crash and burn moments, but also the heroic crash and save interventions, as our experts...

Complications in women: crash and burn or crash and save

Complex STEMI cases: Dextrocardia, thrombosis and coronary aneurysms

05 Oct 2024 – From AICT-AsiaPCR 2024

Prepare to be captivated by a collection of intriguing STEMI cases, curated from the AICT-AsiaPCR 2024 submissions. From a left main PCI in a patient with dextrocardia to a challenging case of primary PCI in an aneurysmal coronary artery, this session promises to push the boundaries...

Complex STEMI cases: Dextrocardia, thrombosis and coronary aneurysms

Navigating complex left main and multivessel coronary disease

05 Oct 2024 – From AICT-AsiaPCR 2024

Delve into the complexities of left main and multivessel disease in this captivating session, featuring selected AICT-AsiaPCR 2024 clinical case submissions. Witness expert cardiologists navigate intricate scenarios, from primary angioplasty of the left main with cardiogenic shock to the management of a complex left main bifurcation...

Navigating complex left main and multivessel coronary disease

Cutting-edge research in interventional cardiology: from coronary stenosis assessment to valve regurgitation treatment

05 Oct 2024 – From AICT-AsiaPCR 2024

Immerse yourself in the latest advancements and insights from the AICT-AsiaPCR 2024 Abstract submissions. This captivating session covers a diverse range of topics, from the cost-effectiveness of functional syntax score versus anatomical syntax score in treatment strategy, to the temporal trends in left main bifurcation PCI....

Cutting-edge research in interventional cardiology: from coronary stenosis assessment to valve regurgitation treatment

Bifurcation PCI with TAP technique - LIVE case

05 Oct 2024 – From AICT-AsiaPCR 2024

A 72-year-old lady with dyslipidemia, hypertension and aspirin intolerance presented an NSTEMI. The coronary angiography showed a distal CX occlusion and a long calcified significant stenosis on proximal LAD with LAD/D3 bifurcation lesion, and a reduced LV function (47%).
Watch the operators as they perform an important...

Bifurcation PCI with TAP technique - LIVE case

How should I treat complex lesion from the intracoronary imaging view?

05 Oct 2024 – From AICT-AsiaPCR 2024

Intracoronary imaging plays a crucial role in guiding treatment strategies for complex lesions. This session delves into the use of various imaging modalities, such as IVUS and OCT, to optimize PCI outcomes. Explore real-world case examples, including a sudden coronary arrest caused by focal stenosis with...

How should I treat complex lesion from the intracoronary imaging view?

Vesalio announces FDA Approval of the NeVa VS™ to treat cerebral vasospasm after aneurysmal rupture

15 Sep 2022

Efficacy and safety of Edoxaban in anticoagulant therapy early after surgical bioprosthetic valve replacement: ENBALV trial

16 Nov 2024

Edoardo Zancanaro provides his take on the ENBALV trial presented by Chisato Izumi at AHA 2024 in Chicago.

Edoardo Zancanaro

Author

Edoardo Zancanaro
ENBALV

The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis

22 Mar 2022

Daniele Giacoppo analyses the main results of the FLAVOUR trial which were presented by Bon-Kwon Koo, from Seoul National University Hospital, South Korea at the American College of Cardiology 2022. 

Daniele Giacoppo

Author

Daniele Giacoppo
The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis

iFR versus angiography-guided CABG: 3-year results of the iCABG randomised trial

31 Oct 2025

Alex Sticchi provides his take on the iCABG trial presented by Rasa Ordiene at TCT 2025, in San Francisco.

Alessandro Sticchi

Author

Alessandro Sticchi
iFR versus angiography-guided CABG: 3-year results of the iCABG randomized trial

TRISCEND II: Two-year outcomes of transcatheter tricuspid valve replacement for severe tricuspid regurgitation

31 Mar 2026

Jonathan Curio provides his take on TRISCEND II trial results presented by Vinod H. Thourani at ACC.26 in New Orleans.

Jonathan Curio

Author

Jonathan Curio
TRISCEND II: Two-Year Outcomes Of Transcatheter Tricuspid Valve Replacement For Severe Tricuspid Regurgitation

Transcatheter aortic valve replacement in small aortic annuli: Results from the FRANCE-TAVI registry

17 Sep 2022

Mirvat Alasnag provides her take on the outcomes of small annuli sub-study from the FRANCE-TAVI Registry which included 1,195 patients. This trial was presented by Walid Ben-Ali at TCT 2022.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Transcatheter aortic valve replacement in small aortic annuli: Results from the FRANCE-TAVI registry

The CLEAR SYNERGY (OASIS 9) Trial: A 2x2 factorial randomized controlled trial of colchicine versus placebo and spironolactone versus placebo in patients with myocardial infarction

18 Nov 2024

Mirvat Alasnag provides her take on the CLEAR SYNERGY trial presented by Sanjit S Jolly at AHA 2024 in Chicago.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
CLEAR SYNERGY
Didn’t find what you were looking for?